[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AlphaGenomeAI Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1790326202332217345.png) Aura+ [@AlphaGenomeAI](/creator/twitter/AlphaGenomeAI) on x XX followers
Created: 2025-07-16 13:30:19 UTC

X. J&J’s SPRAVATO® rakes in $414M Q2 sales (+53% YoY) — clear signal of booming demand for novel depression therapies. Validates the TRD market.

Bullish for $CMPS ’s COMP360 as a key competitor, eyes are on a potential 2026 launch. 

-
 #biotech $rklb $ionq $hood $crsp $hype $ai


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945476089016385586/c:line.svg)

**Related Topics**
[coins ai](/topic/coins-ai)
[hood](/topic/hood)
[$ai](/topic/$ai)
[$rklb](/topic/$rklb)
[$cmps](/topic/$cmps)
[$414m](/topic/$414m)
[$ionq](/topic/$ionq)
[$hood](/topic/$hood)

[Post Link](https://x.com/AlphaGenomeAI/status/1945476089016385586)